Slávka Baróniková shares her opinions on open access publishing and suggests how this can be successfully achieved within pharma.
Listen to Kristen Ratan discuss the benefits and challenges of open access.
As science looks to adapt to the COVID-19 pandemic, the need to publish with transparency, speed and openness is ever greater
The increasing range of publication choices and demand for open access are explored in this sponsored article from Taylor & Francis Group.
cOAlition S Rights Retention Strategy aims to safeguard researchers’ intellectual ownership, enabling embargo-free sharing of research in online repositories.
Analysis of metrics for journals discontinued from Scopus for publication concerns highlights a need for clearer warnings on articles from such journals.
From 2022, journals will need to follow cOAlition S price transparency requirements to get paid. Find out more about the frameworks and potential benefits here.
Following a public consultation, updated cOAlition S guidance relaxes the criteria for transformative journals, prompting commitments from further journals.
Find out more about the principles of the Jussieu Call, which aims to promote bibliodiversity alongside open access in scientific publishing.
Could medical publishing benefit from a more dynamic system, where open publications can be updated and engagement is sought across disciplines?
The latest State of Open Data survey results show changing trends in researchers’ attitudes towards the use of open data.
Scientific publishing is adapting to make research on COVID-19 and coronaviruses freely and rapidly available to all. But does the crisis highlight an opportunity for more fundamental reform?
Find out more about the requirements cOAlition S plans to set for ‘transformative journals’.
With widespread and growing support for increased data sharing, what can we learn from the Yale Open Data Access (YODA) Project and its collaboration with Johnson & Johnson?
UNESCO uses this year’s World Science Day for Peace and Development to examine global disparities in open science.
Tim Ellison, Senior Medical Writer at Oxford PharmaGenesis, discusses a study into the open access policies of leading medical journals
Jackie Marchington, Director of Global Operations at Caudex, discusses good practice for conference abstracts and presentations